Extending anti-estrogen therapy to 10 years reduces breast-cancer recurrence, new cancers
CHICAGO — Researchers said extending anti-estrogen hormone therapy to 10 years reduces the risk of a recurrence of breast cancer in many older women and decreases the chance of a new cancer emerging in the other, healthy breast. The study, which was released Sunday at the annual meeting of the American Society of Clinical Oncology, […]
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Laurie McGinley Tags: biomedical research cancer Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | Hormonal Therapy | Hormones | Study | Women